Dr Paul Lorigan explains what the construction of the new patient treatment centre at The Christie NHS foundation Trust will mean to clinicians. The new facilities will reduce waiting times, allow the delivery of the very best treatments to more patients more efficiently and the development of innovative new treatments. The new centre will be divided into three parts: the chemotherapy facility, the clinical trial research facility and the private patient facility. Dr Lorigan explains how the new research facility will significantly increase the potential for drug development, especially in the field of personalised medicine and talks about the research planned in relation to melanoma and lung cancer.